Aminoglycosides in the Intensive Care Unit: What Is New in Population PK Modeling?
Background: Although aminoglycosides are often used as treatment for Gram-negative infections, optimal dosing regimens remain unclear, especially in ICU patients. This is due to a large between- and within-subject variability in the aminoglycoside pharmacokinetics in this population. Objective: This...
Saved in:
Main Authors: | Alexandre Duong (Author), Chantale Simard (Author), Yi Le Wang (Author), David Williamson (Author), Amélie Marsot (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Model Re-Estimation: An Alternative for Poor Predictive Performance during External Evaluations? Example of Gentamicin in Critically Ill Patients
by: Alexandre Duong, et al.
Published: (2022) -
Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units
by: Séverine Martin-Mons, et al.
Published: (2021) -
Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?
by: Amélie Marsot
Published: (2020) -
Pharmacokinetic Variability in Pediatrics and Intensive Care: Toward a Personalized Dosing Approach
by: Amélie Marsot
Published: (2018) -
Evaluation of aminoglycosides utilization in intensive care units of a teaching hospital in southern Iran
by: Vazin A, et al.
Published: (2019)